Navigation Links
Three CEOs and University President Named Winners of Greater Baltimore Committee's 2008 Baltimore Region Bioscience Awards
Date:3/18/2008

BALTIMORE, March 18 /PRNewswire-USNewswire/ -- Three biotech CEOs and the president of one of the area's major research universities were honored today by the Greater Baltimore Committee as winners of the region's third bioscience award competition.

Winners of the 2008 Greater Baltimore Region Bioscience Awards are:

-- Best New Product or Progress: Timothy E. Askew, President & CEO, CSA Medical, Inc. Askew's very young Baltimore-based company has developed a breakthrough product incorporating a new medical device and use of liquid nitrogen cryo-therapy treatment to literally freeze cancer tissue. The CSA system has been successful in treating esophageal cancer and Barrett's esophagus, a condition that often progresses to esophageal cancer.

-- Entrepreneurship: Dr. Julie D. Suman, co-founder & president, Next Breath, LLC. Suman's five-year-old company, Next Breath, provides contract services to pharmaceutical, biotech and medical device companies that bring new inhalation and nasal products to market. Located at the UMBC incubator in southwest Baltimore County, Next Breath provides services to support the drug development efforts of 45 pharmaceutical companies in the U.S., Canada, Europe and India.

-- Leadership in Bioscience: Dr. Blake M. Paterson, CEO and co-founder, Alba Therapeutics Corporation. Under the leadership of Paterson, Alba Therapeutics has grown in four years from a two-person start-up at the Emerging Technologies Center in Baltimore into a thriving biotechnology company with 45 employees at its headquarters at the University of Maryland, BioPark. Alba is a pioneer in the treatment of Celiac disease, an autoimmune disorder.

-- President's Award: Dr. David J. Ramsay, president, University of Maryland, Baltimore. Dr. Ramsay has championed the growth of biomedical research and technology transfer at UMB, where biotech research has grown by 500 percent since 1994. Ramsay has been the driving force behind the development of the UMB BioPark in west Baltimore. During the last five years, the park has grown to 340,000 square feet of research space and 200 biotech jobs. This year, another 300,000 square feet and 150 more jobs will be added.

Approximately 150 leaders from the Baltimore region's bioscience industry and research community attended the awards presentations at the Renaissance Harborplace Hotel.

"The most important thing that the Greater Baltimore Committee can do is to listen to the voices of individual companies, owners, and researchers -- and find the best ways to support and celebrate the work that you do every day," GBC President & CEO Donald C. Fry told the bioscience researchers, entrepreneurs and advocates.

Nurturing development of the region's bioscience industry is a top priority of the GBC, the region's most prominent organization of business and civic leaders.

Winners of the 2008 Greater Baltimore Region Bioscience Awards were selected by a panel of judges from among 22 nominees submitted by businesses, bioscience advocates, higher education institutions and government agencies.

Judges for this year's awards were: Dr. Ravinder Dhallan, chairman and CEO, Ravgen; Steve Dubin, chief executive officer, Martek Biosciences Corporation; Dr. Aaron H. Heifetz, vice president, business development, Cognate BioServices, Inc.; James Hughes, vice president, research and development, University of Maryland, Baltimore; Dr. Shira Kramer, president, Sterilex Corporation; and Mark E. Rapson, CPA, shareholder and leader, Health & Life Science Group, KAWG&F.


'/>"/>
SOURCE Greater Baltimore Committee
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
2. Tianyin Pharmaceutical Appoints Three New Independent Board Members
3. Three Expert Opinion Journals now Publishing Original Research
4. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
5. China Pharma Appoints Three Independent Non-Executive Directors
6. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
7. Icahn Confirms Intention to Nominate Three Directors at Biogen
8. SDCRM Receives Highest Score in Three of Four Categories from CIRM on Part I of Major Facilities Grant Application
9. Workforce Alliance Concludes Three-Year Biotech Training Program
10. Three Palm Software Receives FDA 510(k) Clearance for Its WorkstationOne(TM) Breast Imaging Workstation
11. Three Steps to Boost Asymchems Investment in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... ... DNA microarray comparative genomic hybridization (array CGH) for HER2 genomic subtyping in ... molecular test results from tumors with previously documented positive, negative, and equivocal ...
(Date:12/2/2016)... ... December 01, 2016 , ... Orthogonal, a ... their recent FDA Class II 510(k) clearance for their flagship medical device, SimplECG. ... remote cardiac monitoring devices that rely on cloth-based nanosensors. While other companies have ...
(Date:12/2/2016)... leader in rapid infectious disease tests, introduced the Company,s newest product, the INSTI HIV ... http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , bioLytical was invited by the Clinton Health ... Self Test to 350 pharmacy representatives in Nairobi and Mombasa, ...
(Date:11/30/2016)... Fla. , Nov. 30, 2016 Biotest ... products, is pleased to announce the addition of its ... Kearney, Nebraska . The 15,200 square ... on November 29th, 2016 and brings the total number ... Ileana Carlisle , BPC,s Chief Executive Officer ...
Breaking Biology Technology:
(Date:11/21/2016)... 21, 2016   Neurotechnology , a provider ... today announced that the MegaMatcher On Card fingerprint ... for the NIST Minutiae Interoperability Exchange (MINEX) ... mandatory steps of the evaluation protocol. ... test of fingerprint templates used to establish compliance ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
(Date:6/22/2016)...  The American College of Medical Genetics and Genomics was ... as one of the fastest-growing trade shows during the Fastest ... in Las Vegas . ... in each of the following categories: net square feet of ... attendees. The 2015 ACMG Annual Meeting was ranked 23 out ...
Breaking Biology News(10 mins):